SynerK Biotech Limited (20240374629). NUCLEIC ACID TARGETING ANGIOTENSINOGEN AND USES THEREOF simplified abstract
Contents
NUCLEIC ACID TARGETING ANGIOTENSINOGEN AND USES THEREOF
Organization Name
Inventor(s)
Weiwen Jiang of Winchester MA (US)
Jimmy Xibai Tang of Hong Kong (HK)
NUCLEIC ACID TARGETING ANGIOTENSINOGEN AND USES THEREOF - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240374629 titled 'NUCLEIC ACID TARGETING ANGIOTENSINOGEN AND USES THEREOF
The present disclosure pertains to biotechnology and reveals a nucleic acid targeting angiotensinogen and its uses. This nucleic acid can effectively inhibit the expression of AGT, potentially treating and preventing diseases associated with elevated AGT expression such as hypertension.
- Nucleic acid targeting angiotensinogen for inhibiting AGT expression
- Treatment and prevention of diseases related to elevated AGT expression
- Potential application in managing hypertension
- Innovative approach to gene therapy in biotechnology
- Specific targeting of AGT for therapeutic purposes
Potential Applications: This technology could be applied in the development of gene therapies for hypertension and other diseases related to elevated AGT expression. It may also have implications in personalized medicine for individuals with genetic predispositions to such conditions.
Problems Solved: This technology addresses the challenge of effectively inhibiting AGT expression, which is crucial in managing diseases like hypertension. By targeting the specific gene responsible for elevated AGT levels, this innovation offers a more precise and potentially more effective treatment approach.
Benefits: The benefits of this technology include the potential for more targeted and personalized treatments for diseases linked to elevated AGT expression. By inhibiting AGT expression, it may help in managing conditions like hypertension more effectively, potentially improving patient outcomes.
Commercial Applications: Title: Innovative Gene Therapy for Hypertension Management This technology could have significant commercial applications in the biopharmaceutical industry, particularly in the development of gene therapies for hypertension and related conditions. It may also attract interest from healthcare providers looking to offer personalized treatment options for patients with genetic predispositions to such diseases.
Prior Art: Readers interested in exploring prior art related to this technology could start by researching gene therapies targeting specific genes involved in hypertension and other cardiovascular diseases. Studies on AGT expression inhibition and its effects on disease management may also provide valuable insights.
Frequently Updated Research: Researchers are continually exploring new approaches to gene therapy and genetic interventions for managing various diseases, including hypertension. Stay updated on the latest studies and clinical trials investigating the efficacy of nucleic acid targeting angiotensinogen in treating conditions related to elevated AGT expression.
Questions about Nucleic Acid Targeting Angiotensinogen:
1. How does this technology specifically target AGT expression for disease management?
- This technology utilizes a nucleic acid that effectively inhibits the expression of AGT, a key factor in diseases like hypertension, offering a targeted approach to treatment.
2. What potential applications does this innovation have beyond treating hypertension?
- Apart from managing hypertension, this technology could potentially be applied in personalized medicine for individuals with genetic predispositions to diseases related to elevated AGT expression.
Original Abstract Submitted
the present disclosure relates to the technical field of biotechnology, and discloses a nucleic acid targeting angiotensinogen and uses thereof. the nucleic acid provided by the present disclosure can effectively inhibit the expression of agt, thereby being capable of treating and/or preventing disease related to elevated agt expression such as hypertension.
